Back
Compass Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.17
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMPX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Compass Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.1 | Buy |
| 20-day SMA: | 5.26 | Sell |
| 50-day SMA: | 4.72 | Buy |
| 200-day SMA: | 3.18 | Buy |
| 8-day EMA: | 5.13 | Buy |
| 20-day EMA: | 5.11 | Buy |
| 50-day EMA: | 4.75 | Buy |
| 200-day EMA: | 3.54 | Buy |
Compass Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 53.96 | Buy |
| Chaikin Money Flow: | 568663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.96 - 5.42) | Sell |
| Bollinger Bands (100): | (3.24 - 4.88) | Buy |
Compass Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics, Inc. Stock
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.17 while CMPX 8-day simple moving average is 5.10, which is a Buy signal.
-
The stock price of CMPX is 5.17 while Compass Therapeutics, Inc. 20-day SMA is 5.26, which makes it a Sell.
-
Compass Therapeutics, Inc. 50-day simple moving average is 4.72 while CMPX share price is 5.17, making it a Buy technically.
-
CMPX stock price is 5.17 and Compass Therapeutics, Inc. 200-day simple moving average is 3.18, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
56
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. a Buy or a Sell?
-
Compass Therapeutics, Inc. stock is rated a BuyThe current Compass Therapeutics, Inc. [CMPX] share price is $5.17. The Score for CMPX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics, Inc. Stock Info
Market Cap:
919.5M
Price in USD:
5.17
Share Volume:
946.1K
Compass Therapeutics, Inc. 52-Week Range
52-Week High:
5.86
52-Week Low:
1.33
Buy
56
Compass Therapeutics, Inc. (CMPX)
is a Buy
Compass Therapeutics, Inc. Share Price Forecast
-
What is the Compass Therapeutics, Inc. stock price today?The Compass Therapeutics, Inc. stock price is 5.17 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics, Inc. is not overvalued.
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 5.17 while CMPX 8-day exponential moving average is 5.13, which is a Buy signal.
-
The stock price of CMPX is 5.17 while Compass Therapeutics, Inc. 20-day EMA is 5.11, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day exponential moving average is 4.75 while CMPX share price is 5.17, making it a Buy technically.
-
CMPX stock price is 5.17 and Compass Therapeutics, Inc. 200-day simple moving average is 3.54, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics, Inc.
Is Compass Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.00 per share.
Technical Analysis of Compass Therapeutics, Inc.
Should I short Compass Therapeutics, Inc. stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Compass Therapeutics, Inc. is a Buy
-
Compass Therapeutics, Inc. Relative Strength Index (RSI) is 53.96, which suggest Compass Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Compass Therapeutics, Inc. is (4.96 - 5.42), which suggest Compass Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics, Inc. is (3.24 - 4.88), which suggest Compass Therapeutics, Inc. is a Buy
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.